Navigation Links
Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
Date:5/30/2009

d NSCLC.

Evaluation of secondary endpoints in the ZODIAC and ZEAL studies showed that the addition of vandetanib to chemotherapy significantly improved objective response rate, which is a measurement of tumor shrinkage (ZODIAC: 17% vs. 10%, P<0.001; ZEAL: 19.1% vs. 7.9%, P<0.001), the studies also showed that adding vandetanib to chemotherapy resulted in a significantly longer time to deterioration of disease related symptoms (ZODIAC: HR 0.78, P=0.002, FACT-L Lung Cancer Subscale; ZEAL: HR 0.61, P=0.004, Lung Cancer Symptom Scale). Overall survival in both studies showed a positive trend, although they did not reach statistical significance (ZODIAC Study: HR 0.91, 97.52% CI 0.78-1.07: P=0.196; ZEAL Study: HR 0.86, 97.54% CI 0.65-1.13; p=0.219).

The observed safety profile in both studies was consistent with previous studies with vandetanib in NSCLC. The most common adverse events associated with vandetanib included rash, diarrhea and hypertension (ZEAL); rash, diarrhea and neutropenia (low white blood cell count) (ZODIAC). Incidence of protocol-defined QTc prolongation was <2.0 percent in both studies and was not associated with symptoms.

"There are more deaths from lung cancer alone than from breast, colon, and prostate cancers combined - and it's extremely difficult to treat," said Professor Roy Herbst, M.D., Ph.D., The University of Texas M. D. Anderson Cancer Center, Texas, Principal Investigator on the ZODIAC study. "The ZODIAC study showed adding vandetanib to chemotherapy improved progression-free survival, in patients who have few, if any options for treatment."

Results from a third Phase III study, ZEST(3), were also presented at this year's ASCO. While the primary objective of demonstrating a statistically significant prolongation of PFS for vandetanib was not met in this study, in a pre-planned non-inferiority analysis, vandetanib was shown to have similar efficacy to
'/>"/>

SOURCE AstraZeneca Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
2. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
3. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
4. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
5. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
6. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
7. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
8. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
9. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
10. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
11. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Pa. , March 3, 2015   ... laboratory products, services and solutions, announced today the ... Biolabs®, Inc. (NEB®). This agreement allows VWR increased ... technical support in the U.S. and Puerto Rico.  ... NEB,s products through VWR,s e-business platform, sales organization, ...
(Date:3/3/2015)... TEL-AVIV, Israel , March 3, 2015 ... or the "Company"), an Israeli biopharmaceutical company ... drugs for inflammatory and gastrointestinal diseases, including ... Goldberg , RedHill,s Chief Business Officer, will ... interactive online event, on Thursday, March 5, ...
(Date:3/3/2015)...  The eleventh annual Tucson Symposium will be held ... research scientists, academics, oncologists and pathologists will gather to ... new outcomes in patient treatments that may significantly affect ... Ventana Medical Systems, Inc. (Ventana), a member of ... at the Hilton El Conquistador in Tucson, ...
Breaking Medicine Technology:VWR Announces Expansion of Distribution Agreement with New England Biolabs 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Aug. 15, 2011 On Friday, August 19, veterinary ... cardiologists on the Mobile Dog Heart Health Tour will ... dog heart examinations at Bark Park in Ridgefield, Conn. ... In addition to providing free heart health screenings, veterinarians ...
... Corporation ("Unilife" or the "Company") (NASDAQ: ... finalized a previously disclosed Equipment Financing Agreement (the ... in available funding. This agreement will immediately replenish ... automated assembly line now manufacturing the Unifill® ready-to-fill ...
Cached Medicine Technology:Free Dog Heart Health Screenings Available August 19 in Connecticut 2Unilife Signs $10 Million Equipment Financing Agreement 2Unilife Signs $10 Million Equipment Financing Agreement 3Unilife Signs $10 Million Equipment Financing Agreement 4
(Date:3/3/2015)... 03, 2015 eMedEvents, a searchable ... medical education (CME) credit information, has officially been ... was initially launched in the United States (December ... kind in the field of healthcare conference technology ... this Denver, Colorado-based start-up company was successful as ...
(Date:3/3/2015)... Auckland, New Zealand and Rockville, Maryland (PRWEB) March ... has selected Cornerstone Communications, LTD as its North ... record. Cornerstone was awarded the Manuka Lab contract ... beauty, and consumer verticals. , Headquartered in Auckland, ... private company focused on providing clients effective, certified ...
(Date:3/3/2015)... State after state prove the ... probation programs aimed to rehabilitate nonviolent drug offenders. ... cost of incarcerating violators of drug laws, as ... addiction treatment. Governor Bruce Rauner ( R)has proposed ... drug and alcohol statewide Department of Alcoholism and ...
(Date:3/3/2015)... York, NY (PRWEB) March 03, 2015 Ticket ... tickets for her 2015 tour. This well-known ticket ... added savings. , Arguably the biggest name in the music ... when Madonna performs on the “Rebel Heart Tour.” Madonna, fresh ... month will kick off her latest tour on August 29th ...
(Date:3/3/2015)... 2015 Raritan Bay Medical Center is ... an interactive photo contest held at the Woodbridge Center ... To raise awareness for health and wellness in the ... their best health and wellness tips. , Photos of ... Center’s website and Facebook page where Facebook users voted ...
Breaking Medicine News(10 mins):Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 3Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2
... PRINCETON, N.J., Feb. 19 Medarex, Inc. (Nasdaq: ... its 2008 fourth quarter and year-end results on ... the financial markets close. Following the release, Medarex,s ... webcast at 4:30 p.m. Eastern Time. To access ...
... CVD ) today announced that it has elected ... Dr. Sheares is former chief executive officer and member of ... company that marketed a portfolio of branded cardiovascular medicines. Prior ... Health division of Merck and Co., Inc., where he led ...
... to know the least, survey finds, , , THURSDAY, Feb. 19 (HealthDay ... of a stroke and what to do if they suspect one ... research. , Older people and those who,ve already had a stroke ... the symptoms of a stroke and know to immediately call 911. ...
... PLC, a subsidiary of MGT Capital Investments, Inc. ... development of Computer-Aided Detection (CAD) and image analysis ... of disease, today announces the following restructuring of ... Rowley, currently Chief Financial Officer, becomes Chief Executive ...
... Feb. 19 A groundbreaking new survey sponsored by ... 82% of young adults aged 18-30 plan to get ... 40% of first marriages end in divorce. Why?"There is ... reality of getting or being married," says Mary Myrick, ...
... 2009 A new study released today found blacks ... replacement, an important intervention for reducing pain and improving ... study also found total knee replacements are increasing substantially ... the research underscores the need for healthcare providers and ...
Cached Medicine News:Health News:Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009 2Health News:Covance Elects Bradley T. Sheares to Company's Board of Directors 2Health News:Know the Warning Signs of Stroke? Most Don't. 2Health News:Medicsight PLC Restructures Management Team 2Health News:Medicsight PLC Restructures Management Team 3Health News:Young People Want 'Happily Ever After,' but Lack Skills to Make Marriage Work 2Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 2Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: